Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Hospital

Hospital

Julien Tiete, Dr

Hôpital Erasme - ULB
" Background: In the Covid-19 pandemic context, all healthcare teams face clinical, organizational and technical challenges given the contagion, severity and mortality characteristics of the disease. Methods: A cross-sectional multicentric study (NCT04344145) aiming to compare levels of burnout, emotional distress and needs between frontline Covid-19 and non-Covid-19 healthcare workers has been conducted between April 16th and May 25th. Physicians, nurses and physiotherapists were recruited from emergency care units and Covid-19 care units (target group) and from non-Covid-19 care units (control group) from Erasme Hospital, Jolimont-Lobbes Hospital and Mons-Warquignies Hospital (N = 603). Participants completed self-reported questionnaires and scales. A mixed-mode data collection was carried out, either in paper form or web-based form. Assessment provided socio-demographic characteristics and professional information. It also measured professional fulfillment and...

Marie-Pierre HAYETTE, The RT-PCR diagnostic platform of CHU Liège for the detection of SARS-CoV-2

CHU-Liège 
" The University Hospital of Liège (CHULiège) has developed a diagnostic capability to detect the SARS-CoV-2 by RT-PCR in response to the need for more capacity testing in Belgium from March 2020. Indeed, from February 2020, clinical COVID-19 cases were already detected in Belgium thanks to the Reference laboratory for respiratory viruses in KULeuven (Reflab). However, it appeared rapidly evident that the capacity of the Reflab could not be further enhanced. Therefore Belgian university and non-university hospital laboratories started to develop RT-PCR assays which sensitivity were first validated by the Reflab. CHULiège developed an in house SARS-CoV-2 RT-PCR assay following an adapted version of the Charité Hospital (1) protocol with the aid of the Antwerp University Hospital Microbiology lab and the Reflab. We have chosen to include two targets: the E and RNA-dependent RNA polymerase (RdRP) genes. From the 6th March, we were able to run the test and since this date we run...

Maya Hites, Associate Professor

CUB-Erasme
" "Background: There are no currently approved therapeutics for COVID-19 disease. This disease causes significant morbidity and mortality. Main Objectives: The overall objective of the study is to evaluate the clinical efficacy and safety of different investigational therapeutics relative to the control arm in patients hospitalized with COVID-19 patients. The primary endpoint is subject clinical status (on a 7-point ordinal scale) on Day 15. The secondary objectives are to evaluate clinical, and virological efficacy, and safety of different investigational therapeutics as compared to the control arm. Study design: This is a prospective, worldwide, adaptive, randomized, controlled, open study comparing 4 different treatments for COVID-19. The protocol is based on the WHO Master protocol of the Solidarity trial. The DisCoVeRy protocol previews more data collection and lower dosage regimens of Hydroxychloroquine than in the SOLIDARITY trial. Randomization is performed by...

Maya Hites, Associate Professor

CUB-Erasme
" "a. Background Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a new coronavirus SARS CoV-2, responsible for the current pandemic, causing a lot of morbidity and mortality. Most people with COVID-19 develop mild respiratory illness (stage I). However, in a sub-group of patients (+/- 15%) there are increasing respiratory symptoms and persistent fever (stage II). Patients may develop acute lung injury (hypoxia, and bilateral opacities on chest computed tomography (CT-scan)), requiring hospitalisation. A further 5% of patients develop stage III disease, requiring admission to the intensive care unit (ICU) due to acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multi-organ failure. As patients progress from stage I to stage III, there are increasing signs of systemic hyper-inflammatory response, reflected by high levels of cytokines, C-reactive protein (CRP), ferritin, and lymphopenia. Different viral, bacterial, and...

Michelle Nisolle, Professor - Vincent Rigo, Professor - Katty Delbecque, Doctor

ULiège, CHU, Obstetrics and Gynecology - Royal Academy of Medicine of Belgium
" The primary objective of the project is to assess the risk of maternal-fetal transmission of the SARS-CoV-2 virus. The secondary objectives are to analyze the impact of COVID-19 infection on the course of pregnancy as well as that of the newborn. This is a prospective study of a positive COVID-19 pregnant patients cohort in a population of 2,500 patients who give birth in the Gynecology-Obstetrics Department at CHR-Liège. Samples will be taken from the mother, the newborn and from the placenta during childbirth from patients who were diagnosed with COVID-19 during pregnancy or when they were admitted to the delivery unit. Obstetric and neonatal repercussions will be analyzed. "
Funding: Fondation Leon Fredericq
Contact: Pr Michelle Nisolle This email address is being protected from spambots. You need JavaScript enabled to view it.

Mickael Aoun, Infectiologist

Bordet Institute
" On April 11th, 2020, four patients hospitalized for more than 7 days developed fever some of them respiratory symptoms compatible with Covid-19 infection and were detected positive for SARS-CoV2. A 5th patient was also detected positive , had minor symptoms and was admitted 2 days earlier for collecting PBSC As a consequence of this mini-outbreak a screening of healthcare workers at this Unit revealed 2 staff members positive for SARS-CoV2. Severe acute respiratory distress syndrome Coronavirus 2(SARS-CoV2), causing Covid19 pandemic is rapidly spreading from person-to-person, via respiratory droplets, direct contact with mucous membranes or indirect contact through touching infected surfaces and then touching own eyes, nose or mouth. Airborne transmission after generated aerosols (intubation, bronchoscopy, tracheal aspiration,…) have been previously reported for other Coronaviruses(SARS-CoV1, MERS) and has been postulated for SARS-Cov2. In critical units such as the...

Mona Momeni, MD, PhD

UCLouvain/Cliniques universitaires Saint-Luc 
" COVID-19 pandemic has an important impact on the health care provided by the anesthesiologists. Different societies of anesthesiology have provided guidelines and recommendations on how to manage patients who have been tested positive for COVID-19 or suspected to be infected. It is therefore important to know whether these guidelines have been implemented or were possible to be implemented. Otherwise patients who are presenting COVID-19 often show pulmonary complications. The airway management and the ventilation management of these patients can be therefore challenging and can possibly influence their outcome. It is thus important to obtain a large database with information about the characteristics of these patients, how these patients have been managed and their in-hospital outcome. Information regarding the correct implementation of guidelines is as well necessary for future guidance of health care providers. "
Funding: None
Contact...

O. Vandenberg, Pr. - N. Clumeck, Pr. - C. Montesinos, Pr. - N. Dauby, MD, PhD - C. Gilles, MD - C. Martin, MD - S. Van den Wijngaert, MD - A. Marchant, Pr. - D. Martiny, Pr. - S. De Wit, Pr.

LHUB-ULB - Royal Academy of Medicine of Belgium
" "The purpose of this study is to map the healthcare workers exposure risk in Saint-Pierre University Hospital by combining molecular methods with serological assays. In summary, the short-term objective is threefold: (1) Provide an estimate of the sero-prevalence at baseline among high-risk health care workers (2) Determine prospectively the incidence of new SARS-CoV-2 infections among high-risk health care workers (3) Estimate the healthcare worker exposure to the virus by serological data to help our five partner hospitals in their day-to-day management of the ongoing pandemic The mid-term objectives are: (1) Establish an accurate mapping of the spread of the virus among our population allowing to identify the chain of transmission, (2) Identify predictive immunological markers of susceptibility to infection and disease severity to inform vaccine strategies and, (3) Establish solid diagnosis algorithm that will help adequate lockdown...

Olivier Debeir, Professor - Olivier Van Hove, Kinesiologist

ULB/ERASME
" Severe COVID-19 patients have a greater risk of long-term health issues and sometimes develop permanent lung damage or fibrosis needing a long treatment to enhance their quality of life. The project aims to better quantify the breathing parameters of a patient to assess his revalidation evolution. A 3D image acquisition based system, provides contacless and non invasive measure. The system can be used as a complementary diagnosis tools as well for a quantitative follow up. "
Funding: So far the project is supported by volunteering inside the ULB/Laboratory of Image Synthesis and Analysis (LISA) and the Erasme Hospital
Contact: Olivier Debeir < This email address is being protected from spambots. You need JavaScript enabled to view it.> & Olivier Van Hove < This email address is being protected from spambots. You need JavaScript enabled to view it.>

Olivier DURANTEAU, Doctor

Erasme Hospital
" Precise the frequency of thrombosis events in COVID19 patients "
Funding: No need
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Pascale Huynen, Dr

CHU of Liège
" The aim of this study is to search for the presence of antibodies against SARS-CoV-2 in the staff of CHU de Liège and University of Liège, and to follow the evolution of antibody levels on blood samples taken 1.5 and 3 months after the first sample. This will allow to : • carry out a COVID-19 seroprevalence study by assaying anti-SARS-CoV-2 antibodies in people in contact with patients, compared to a population of "negative control" subjects, at baseline and 1.5 and 3 months after the first testing ; • observe the evolution of antibody levels between samples; • highlight possible seroconversion between samples in asymptomatic persons "
Funding: Wallonia Region CHU of Liège University of Liège Fondation Léon Frédéricq
Contact: Dr Pascale Huynen, Dpt of Clinical Microbiology, CHU of Liège and University of Liège Prof Pierrette Melin, Dpt of Clinical Microbiology, CHU of Liège and University of Liège Prof Yves Beguin, Dpt of Hematology, CHU of Liège and University of...

Patrice Cani, FNRS Senior Research Associate - Leïla Belkhir, PhD - Jean Ruelle, PhD - Julien De Greef, MD- Benoit Kabamba, PhD - Vincent Haufroid, PhD - Laure Elens, PhD - Jean Cyr Yombi, MD

Cliniques universitaires Saint-Luc, UCLouvain
" The objective of our project is to describe the nasopharyngeal (NP) microbiota and virome of SARS-CoV-2 infected patients at diagnosis through unbiased nextgeneration sequencing analysis and to correlate microbiota and virome profile with COVID-19 infectious phenotype. At a second stage of our project, provided additional findings are raised, those data will be enriched by NP transcriptome analysis of infected patients, and background genomic determination. Integration of those data and analysis through systems biology approach will enable better understanding of multidirectional host-pathogen interactions. "
Funding: FNRS CUR requested. Additional funding will be requested for further steps.
Contact: Pr L.Belkhir This email address is being protected from spambots. You need JavaScript enabled to view it. 02/7642198 --- Pr P.Cani This email address is being protected from spambots. You need JavaScript enabled to view it.

Ph. DELVENNE, FNRS Research Director / Chef de service Anatomie pathologique - J. GUIOT, Chef de clinique Pneumologie - L. RENAUD, Chef de service Pneumologie - M. MOUTSCHEN, Chef de service Infectiologie- B. MISSET, Chef de service Soins Intensifs

ULiège, CHU - Royal Academy of Medicine of Belgium
" Nous faisons face à une pandémie d'infection COVID-19. Ce virus pathogène est source de complications pulmonaires aggravant fortement le pronostic de nos patients. De nos jours, tant les mécanismes physiopathologiques en cause que les marqueurs de sévérité de l'atteinte restent indéterminés. Il apparaît donc comme urgent de pouvoir identifier des marqueurs diagnostiques, pronostiques et prédictifs pour nos patients. Dans ce contexte, plusieurs voies rapidement explorables nous apparaissent comme critiques. Le but final de cette étude est de contribuer à une prise en charge plus ciblée des patients porteurs d'une infection au SRAS-Cov-2. "
Funding: Fonds Léon Frederic
Publication References: Dix publications représentatives : 1) Prevention of murine radiogenic thymic lymphomas by tumor necrosis factor or by marrow grafting. HUMBLET C, GREIMERS R, DELVENNE P, DEMAN J, BONIVER J, DEFRESNE MP. J Natl Cancer Inst 88 (1996), 824-831. IF...

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Pierre Smeesters, Professor

HUDERF and ULB
" Role of Children in Sars-Cov-2 transmission, Heath Care Worker protection, Paediatric epidemiology and disease burden "
Funding: FNRS funding under assessment.
Contact: Prof Pierre Smeesters Academic Children Hospital Queen Fabiola Molecular Bacteriology Laboratory, ULB This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19